S-1/A: Guardian Pharmacy Services Amends Loan Agreement, Waives Defaults Ahead of Potential IPO

Sentiment:

Loan Agreement Amendment


Guardian Pharmacy Services secures a sixth amendment to its loan agreement, waiving existing defaults and paving the way for its initial public offering.

Delay expectedThe Borrower has notified the Agent and the Lenders that certain Events of Default have occurred and are continuing under Section 10.1(c) of the Existing Loan Agreement as a result of the Credit Parties failure to comply with the requirements of Section 8.17 of the Existing Loan Agreement.
Capital raiseThe document references a proposed IPO and related joinders, indicating a potential public offering of Guardian Pharmacy Services stock.The definition of Qualifying IPO in Section 1.1 of the Existing Loan Agreement is hereby amended and restated in its entirety to read as follows: Qualifying IPO means an underwritten primary public offering of the common stock of the Borrower (or Borrowers successor in interest or any other Person who becomes Borrower hereunder, in each case, pursuant to a Qualifying IPO Permitted Restructuring) (a) pursuant to an effective registration statement filed with the United States Securities and Exchange Commission in accordance with the Securities Act (whether alone or in conjunction with a secondary public offering) and (b) resulting in gross proceeds of at least $30,000,000.For the avoidance of doubt, it is understood and agreed that the Proposed IPO is a Qualifying IPO.

Summary

  • Guardian Pharmacy, LLC has entered into a Sixth Amendment to its Third Amended and Restated Loan and Security Agreement with Regions Bank, as agent, and other lenders.
  • The amendment addresses existing events of default related to non-compliance with Section 8.17 of the Existing Loan Agreement and waives these defaults.
  • The lenders have also agreed to certain modifications to the Existing Loan Agreement and the Pledge Agreement.
  • A new term loan of $15.0 million was added to the Credit Facility.
  • The amendment extends the maturity date of the credit facility from April 23, 2025, to April 23, 2027.
  • The interest rate on the line of credit is now the one-month Secured Overnight Financing Rate (SOFR) plus an additional rate of 1.80% to 2.80% based on certain financial ratios.
  • The interest rate of the Term Loan bears an interest rate equal to the one-month SOFR plus an additional rate of 1.80% to 2.80% based on certain financial ratios.
  • The Term Loan is payable in quarterly installments of $1.4 million through March 31, 2027, with the remaining balance of the Term Loan due in a final lump sum payment at maturity on April 23, 2027.
  • The amendment is effective upon satisfaction of specific conditions, including receipt of executed counterparts, officer's certificates, and payment of agent's expenses.
  • The credit parties reaffirm their obligations and security interests under the loan documents.
  • The document also references a proposed IPO and related joinders, indicating a potential public offering of Guardian Pharmacy Services stock.
  • The document includes schedules detailing existing indebtedness, liens, and corporate structure.

Sentiment

Score: 7

Explanation: The document is generally positive, indicating a successful amendment of the loan agreement and a waiver of existing defaults. The mention of a potential IPO is also a positive sign. However, the fact that the company was in default of its loan agreement is a negative.

Positives

  • The amendment provides Guardian Pharmacy with more financial flexibility.
  • The waiver of existing defaults removes a potential obstacle to the company's operations.
  • The extension of the maturity date provides more time for the company to repay its debt.
  • The new term loan provides additional capital for the company.

Negatives

  • The amendment indicates that the company was in default of its loan agreement.
  • The company is still subject to financial covenants and other restrictions under the loan agreement.

Risks

  • Failure to comply with the terms of the amended loan agreement could result in future defaults.
  • The company's ability to repay its debt is dependent on its financial performance.
  • The company's proposed IPO may not be successful.

Future Outlook

The document suggests a potential IPO for Guardian Pharmacy Services, with related actions to be taken upon the IPO's effective date.

Industry Context

The document reflects ongoing financial management and strategic positioning within the pharmacy services sector, particularly in anticipation of a potential public offering. The loan amendment and waiver provide the company with a cleaner financial slate and extended runway, which are attractive qualities for potential investors.

Comparison to Industry Standards

  • It is difficult to compare the results to industry standards without knowing the specific financial ratios and performance metrics of Guardian Pharmacy Services and its competitors.
  • However, the document does provide some information that can be used to make some general comparisons.
  • For example, the document states that the interest rate on the line of credit is now the one-month Secured Overnight Financing Rate (SOFR) plus an additional rate of 1.80% to 2.80% based on certain financial ratios.
  • This is a relatively common interest rate for a line of credit of this size and risk profile.
  • The document also states that the company is in compliance with all debt covenants.
  • This is a positive sign, as it indicates that the company is managing its debt responsibly.
  • Overall, the document suggests that Guardian Pharmacy Services is a well-managed company with a solid financial position.
  • However, it is important to note that the document does not provide enough information to make a definitive assessment of the company's performance relative to its competitors.

Stakeholder Impact

  • Shareholders: Potential for increased value if the IPO is successful.
  • Lenders: Continued interest payments and potential for increased returns.
  • Employees: Job security and potential for increased compensation.
  • Customers: Continued access to pharmacy services.

Next Steps

  • Satisfaction of conditions precedent for the amendment to become effective.
  • Potential actions related to the proposed IPO, including joinders and compliance with specific sections of the agreement.

Key Dates

DateDescription
April 23, 2018Date of the original Third Amended and Restated Loan and Security Agreement.
December 3, 2019Date of the First Amendment to the Loan Agreement.
March 20, 2020Date of the Second Amendment to the Loan Agreement.
December 22, 2021Date of the Third Amendment to the Loan Agreement.
April 22, 2022Date of the Fourth Amendment to the Loan Agreement.
October 13, 2023Date of the Fifth Amendment to the Loan Agreement.
May 13, 2024Date of the Sixth Amendment to the Loan Agreement and Waiver.
April 23, 2027Extended maturity date of the credit facility.

Keywords

loan agreement, amendment, default, Regions Bank, Guardian Pharmacy, credit facility, IPO, Term SOFR, Obligations, Lenders

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.